The Middle East market is a primary focus for ForaCare. The company’s blood glucose monitors are currently being sold in Saudi Arabia, Kuwait and UAE. ForaCare appointed Mr. Hazem Hamdy as Business Development Director for the Middle East and North Africa (MENA) region in November 2012 and recently established ForaMed as an exclusive distributor of ForaCare Suisse AG in the Middle East and North Africa (www.foracare.me).
"On behalf of ForaCare, we look forward to growing our presence in the MENA region and offering additional blood glucose and blood pressure monitoring devices to give patients enhanced mobility, increased measurement accuracy and expanded sharing capabilities with their health care networks," stated Mr. Hamdy. "I am pleased to work in collaboration with Mr. Bassem Abdullah, Country Manager of UAE and Oman, who has extensive experience achieving growth in the blood glucose, blood pressure and diagnostic product markets."
Up next in 2014, ForaCare will launch the FORA Diamond Wireless Full Care product line that utilizes Bluetooth connectivity to offer the highest level of mobility and data sharing capabilities for patients on the go. The four products in the initial portfolio will include the Diamond MINI, Diamond CUFF BP monitor, ACTIVE WIRELESS plus blood pressure monitor and the FORA W310b weight scale. Members of the health care community will have the opportunity to learn more about the FORA Diamond Wireless Full Care system when the product line microsite launches in March on the ForaCare Suisse AG corporate website located at http://www.foracare.ch/.
Additionally, ForaCare will launch the Diamond CUFF BP blood pressure monitor in Europe mid-year with an exhibit at the joint meeting of the European Society of Hypertension (ESH) and International Society of Hypertension (ISH) in Athens, Greece, June 13-16, 2014. Along with user studies in Greece and Australia, the Diamond CUFF BP has been tested in accordance with ESH 2010 guidelines and the results will be published in the second half of the year.
ForaCare is looking forward to expanding its reach with continued innovation, focusing on improving the wellbeing and quality of life for patients with diabetes-related health conditions.
ForaCare Suisse AG Measurement Standards:
ForaCare devices comply with new ISO 15197 standards and have completed third party validations:
About ForaCare Suisse AG:
ForaCare provides FDA cleared and CE marked innovative health monitoring devices that provide a simple connection to the FORA system. Our ultimate vision is to employ innovative technologies and services in expanding the scope of total health management platforms and to improve the quality of self-homecare for diabetes and hypertension patients. For more information, please visit: http://www.foracare.ch/